You have 9 free searches left this month | for more free features.

interferon-gamma release assay

Showing 1 - 25 of 9,308

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

CD4/CD8+ Interferon Gamma Release Assay for Monitoring

Active, not recruiting
  • Tuberculosis
  • Interferon gamma release assay (IGRA)
  • Milano, Italy
    IRCCS San Raffaele Scientific Institute
Feb 13, 2023

Interferon-Gamma Release Assays in Tuberculosis - HIV

Completed
  • Tuberculosis
  • HIV
  • Interferon-Gamma Release Assay
  • RT-23
  • Cape Town, Western Cape, South Africa
    University of Stellenbosch
Jan 3, 2022

Assess the IGRA Positivity in Populations With a High TB Burden

Recruiting
  • Tuberculosis, Pulmonary
    • Bloemfontein, South Africa
    • +8 more
    Apr 6, 2022

    Tuberculous Uveitis Trial in Jakarta Pusat (Anti Tuberculosis Drug, Prednisone tablet)

    Enrolling by invitation
    • Tuberculous Uveitis
    • Anti Tuberculosis Drug
    • Prednisone tablet
    • Jakarta Pusat, DKI Jakarta, Indonesia
      Cipto Mangunkusumo National Central General Hospital
    Sep 12, 2021

    Sarcoidosis, SARS-CoV2 Infection, Vaccine Response Impaired Trial in Chicago (Assay of (1) the level of anti-spike IgG antibody,

    Recruiting
    • Sarcoidosis
    • +2 more
    • Assay of (1) the level of anti-spike IgG antibody, and (2) interferon-gamma release in response to SARS-CoV-2 antigen stimulation
    • Chicago, Illinois
      Northwestern Medicine
    Dec 6, 2021

    HIV I Infection, Tuberculosis Trial in South Africa (MTBVAC, BCG)

    Not yet recruiting
    • HIV I Infection
    • Tuberculosis
    • MTBVAC
    • BCG
    • Westdene, Gauteng,, South Africa
    • +15 more
    Jul 21, 2023

    Tuberculosis; Uveitis (Manifestation), Anti-Tuberculous Drug Reaction, Tuberculous Uveitis Trial in Jakarta Pusat (Fixed drug

    Unknown status
    • Tuberculosis; Uveitis (Manifestation)
    • +2 more
    • Fixed drug combination (FDC) of ATT and Oral steroid
    • Jakarta Pusat, Jakarta, Indonesia
      RSUPN dr. Cipto Mangunkusumo (Cipto Mangunkusumo Hospital)
    Oct 1, 2019

    Methods in People Living With Retroviral Infection in Liberia

    Active, not recruiting
    • Tuberculosis
    • HIV
      • Bethesda, Maryland
      • +4 more
      Jan 14, 2023

      Performance Evaluation of the VIDAS TB-IGRA Assay.

      Completed
      • Active Tuberculosis
      • +2 more
      • Blood draw and IGRA test
      • Palo Alto, California
      • +23 more
      Jul 14, 2021

      Metastatic Myxoid Liposarcoma, Metastatic Round Cell Liposarcoma, Metastatic Synovial Sarcoma Trial in United States (Interferon

      Active, not recruiting
      • Metastatic Myxoid Liposarcoma
      • +15 more
      • Interferon Gamma-1b
      • +2 more
      • Palo Alto, California
      • +6 more
      Aug 2, 2022

      Chronic Kidney Disease 5D, Chronic Kidney Disease 5T Trial in Istanbul (SARS-CoV-2 mRNA BNT162b2 vaccine (Pfizer-BioNTech®))

      Completed
      • Chronic Kidney Disease 5D
      • Chronic Kidney Disease 5T
      • SARS-CoV-2 mRNA BNT162b2 vaccine (Pfizer-BioNTech®)
      • Istanbul, Turkey
      • +5 more
      Jul 19, 2022

      Interferon Gamma Release Assays in Predicting Active

      Completed
      • Tuberculosis
      • Latent Tuberculosis
        • Southall, London, United Kingdom
        • +2 more
        Sep 29, 2020

        Acute Leukemia, MDS Trial in Atlanta (Interferon gamma (IFN?)-primed human bone marrow-derived mesenchymal stromal cells)

        Recruiting
        • Acute Leukemia
        • Myelodysplastic Syndromes
        • Interferon gamma (IFNγ)-primed human bone marrow-derived mesenchymal stromal cells
        • Atlanta, Georgia
        • +2 more
        Jul 15, 2022

        Tuberculin Skin Test and Interferon-Gamma Release Assays in

        Completed
        • Latent Tuberculosis Infection
        • Tuberculosis
          • Phoenix, Arizona
          • +9 more
          Jan 27, 2021

          HIV Seropositivity, Immunodeficiency, Vaccination Reaction Trial in Ghent (Blood draw)

          Recruiting
          • HIV Seropositivity
          • +3 more
          • Blood draw
          • Ghent, East Flanders, Belgium
            UH Ghent
          Jan 4, 2023

          Tuberculosis Trial (BNT164a1, BNT614b1, Placebo)

          Not yet recruiting
          • Tuberculosis
          • BNT164a1
          • +2 more
          • (no location specified)
          Jan 18, 2023

          Bullous Dermatoses, Psoriasis, COVID-19 Vaccines Trial in Ratchathewi (tozinameran)

          Recruiting
          • Bullous Dermatoses
          • +2 more
          • tozinameran
          • Ratchathewi, Bangkok, Thailand
            Dermatology outpatient clinic, Somdech Phra Debaratana Medical C
          Aug 22, 2022

          Latent Tuberculosis Trial in Ramat Gan, Ramat-Gan (Answering the study Questionnaire and blood sampling for Interferon gamma

          Completed
          • Latent Tuberculosis
          • Answering the study Questionnaire and blood sampling for Interferon gamma release assay (IGRA)
          • Ramat Gan, Israel
          • +1 more
          Jan 24, 2019

          Adenovirus, Cytomegalovirus Infections, Epstein-Barr Virus Infections Trial in Pittsburgh (Specific T- Lymphocytes)

          Not yet recruiting
          • Adenovirus
          • +2 more
          • Specific T- Lymphocytes
          • Pittsburgh, Pennsylvania
            UPMC Children's Hospital of Pittsburgh
          Sep 8, 2023

          Tuberculosis Trial in Worldwide (M72/AS01E-4 Mycobacterium tuberculosis investigational vaccine, Placebo)

          Not yet recruiting
          • Tuberculosis
          • M72/AS01E-4 Mycobacterium tuberculosis investigational vaccine
          • Placebo
          • Bandung, Indonesia
          • +59 more
          Sep 25, 2023

          Gastric Adenocarcinoma, Esophageal Adenocarcinoma Trial in Netherlands (Capecitabine, Oxaliplatin, Retifanlimab)

          Recruiting
          • Gastric Adenocarcinoma
          • Esophageal Adenocarcinoma
          • Amsterdam, Netherlands
          • +7 more
          Jan 31, 2022

          Worse Outcome Post-Sars-CoV-2 Infection

          Completed
          • COVID-19
          • +2 more
            • Johannesburg, Gauteng, South Africa
              The Aurum Institute
            Jan 9, 2023

            Rheumatoid Arthritis Trial in Dhaka (Baricitinib 4 MG, Baricitinib 2 MG)

            Recruiting
            • Rheumatoid Arthritis
            • Baricitinib 4 MG
            • Baricitinib 2 MG
            • Dhaka, [Other], Bangladesh
              Dr. Md. Sadikul islam
            Dec 13, 2022

            Interferon-gamma In Immune Responses To Invasive Candidiasis

            Recruiting
            • Fungal Infection
            • Candidiasis
              • Rochester, Minnesota
                Mayo Clinic Rochester
              Mar 11, 2022

              Latent Tuberculosis, Persistent Infection, Mycobacterium Tuberculosis Trial in Malmö

              Recruiting
              • Latent Tuberculosis
              • +2 more
                • Malmö, Skåne, Sweden
                  Skåne University Hospital
                Nov 10, 2022